|Study Description:||The goal of this clinical research study is to learn if LY2090314 can help to |
control the disease in patients with AML. The safety and difference in dose
levels of this drug will also be studied.
LY2090314 is a drug that stops DNA (the genetic material of cells) growth in
which leukemias are dependent upon for their survival.